H13 anticorps (AA 336-377) (HRP)
-
- Antigène Voir toutes H13 Anticorps
- H13 (Histocompatibility 13 (H13))
-
Épitope
- AA 336-377
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp H13 est conjugé à/à la HRP
-
Application
- ELISA
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Minor histocompatibility antigen H13 protein (336-377AA)
- Isotype
- IgG
- Top Product
- Discover our top product H13 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- H13 (Histocompatibility 13 (H13))
- Autre désignation
- HM13 (H13 Produits)
- Synonymes
- anticorps H13, anticorps IMP1, anticorps IMPAS, anticorps IMPAS-1, anticorps MSTP086, anticorps PSENL3, anticorps PSL3, anticorps SPP, anticorps SPPL1, anticorps dJ324O17.1, anticorps cb228, anticorps zgc:56660, anticorps zgc:86862, anticorps wu:fc11a06, anticorps h13, anticorps MGC68919, anticorps 1200006O09Rik, anticorps 4930443L17Rik, anticorps 5031424B04Rik, anticorps AV020344, anticorps H-13, anticorps Hm13, anticorps Spp, anticorps histocompatibility minor 13, anticorps histocompatibility (minor) 13, anticorps histocompatibility (minor) 13 L homeolog, anticorps histocompatibility 13, anticorps HM13, anticorps hm13, anticorps hm13.L, anticorps H13, anticorps Hm13
- Sujet
-
Background: Catalyzes intramembrane proteolysis of some signal peptides after they have been cleaved from a preprotein, resulting in the release of the fragment from the ER membrane into the cytoplasm. Required to generate lymphocyte cell surface (HLA-E) epitopes derived from MHC class I signal peptides (PubMed:11714810). May be necessary for the removal of the signal peptide that remains attached to the hepatitis C virus core protein after the initial proteolytic processing of the polyprotein (PubMed:12145199). Involved in the intramembrane cleavage of the integral membrane protein PSEN1 (PubMed:12077416, PubMed:11714810, PubMed:14741365). Cleaves the integral membrane protein XBP1 isoform 1 in a DERL1/RNF139-dependent manner (PubMed:25239945). May play a role in graft rejection (By similarity).
Aliases: dJ324O17.1 antibody, H13 antibody, hIMP1 antibody, Histocompatibility (minor) 13 antibody, HM13 antibody, HM13_HUMAN antibody, IMP-1 antibody, IMP1 antibody, IMPAS antibody, IMPAS-1 antibody, Intramembrane protease 1 antibody, Intramembrane protease antibody, Minor histocompatibility antigen 13 antibody, Minor histocompatibility antigen H13 antibody, MSTP086 antibody, OTTHUMP00000030527 antibody, OTTHUMP00000030528 antibody, OTTHUMP00000030530 antibody, OTTHUMP00000214528 antibody, Presenilin-like protein 3 antibody, PSENL3 antibody, PSL3 antibody, Signal peptide peptidase antibody, Signal peptide peptidase beta antibody, SPP antibody
- UniProt
- Q8TCT9
-